Amikacin@SiO2 core@shell nanocarriers to treat pulmonal bacterial infections

AMC@SiO 2 core@shell nanocarriers (AMC: amikacin) with 200 nm AMC core, 20 nm silica shell, and unprecedented AMC load (80%) show high activity against Mycobacterium tuberculosis and Mycobacterium abscessus as pulmonal, often multiresistant bacteria.